Related references
Note: Only part of the references are listed.Glycyrrhizic acid ameliorates the kynurenine pathway in association with its antidepressant effect
Bo Wang et al.
BEHAVIOURAL BRAIN RESEARCH (2018)
The inhibition of the kynurenine pathway prevents behavioral disturbances and oxidative stress in the brain of adult rats subjected to an animal model of schizophrenia
Gislaine Z. Reus et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2018)
The molecular aspects of oxidative & nitrosative stress and the tryptophan catabolites pathway (TRYCATs) as potential causes of depression
Paulina Wigner et al.
PSYCHIATRY RESEARCH (2018)
Targeting Oxidative Stress, Cytokines and Serotonin Interactions Via Indoleamine 2, 3 Dioxygenase by Coenzyme Q10: Role in Suppressing Depressive Like Behavior in Rats
Sally A. Abuelezz et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2017)
Oxidative Stress and Inflammation in Early Onset First Episode Psychosis: A Systematic Review and Meta-Analysis
David Fraguas et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2017)
Pathophysiological mechanisms involved in the relationship between diabetes and major depressive disorder
Gislaine Z. Reus et al.
LIFE SCIENCES (2017)
Social stress induces neurovascular pathology promoting depression
Caroline Menard et al.
NATURE NEUROSCIENCE (2017)
Kynurenic Acid in Schizophrenia: A Systematic Review and Meta-analysis
Eric Plitman et al.
SCHIZOPHRENIA BULLETIN (2017)
Serum kynurenic acid is reduced in affective psychosis
B. E. Wurfel et al.
TRANSLATIONAL PSYCHIATRY (2017)
Maternal Inflammation Results in Altered Tryptophan Metabolism in Rabbit Placenta and Fetal Brain
Monica Williams et al.
DEVELOPMENTAL NEUROSCIENCE (2017)
Discovery of IDO1 Inhibitors: From Bench to Bedside
George C. Prendergast et al.
CANCER RESEARCH (2017)
Melatonin attenuates behavioural deficits and reduces brain oxidative stress in a rodent model of schizophrenia
Adejoke Y. Onaolapo et al.
BIOMEDICINE & PHARMACOTHERAPY (2017)
Desipramine decreases expression of human and murine indoleamine-2,3-dioxygenases
Alexandra K. Brooks et al.
BRAIN BEHAVIOR AND IMMUNITY (2017)
Indoleamine-2,3-Dioxygenase/Kynurenine Pathway as a Potential Pharmacological Target to Treat Depression Associated with Diabetes
Isabella Caroline da Silva Dias et al.
MOLECULAR NEUROBIOLOGY (2016)
Relationship between neurotoxic kynurenine metabolites and reductions in right medial prefrontal cortical thickness in major depressive disorder
Timothy B. Meier et al.
BRAIN BEHAVIOR AND IMMUNITY (2016)
Stress-Related Immune Markers in Depression: Implications for Treatment
Martina M. Hughes et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2016)
Inflammation Models of Depression in Rodents: Relevance to Psychotropic Drug Discovery
Jennifer L. Remus et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2016)
Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015
Theo Vos et al.
LANCET (2016)
Cerebral revascularization for the treatment of patients with acute ischemic stroke
V. V. Krylov et al.
Zhurnal Nevrologii I Psikhiatrii imeni S S Korsakova (2016)
A role for inflammatory metabolites as modulators of the glutamate N-methyl-D-aspartate receptor in depression and suicidality
Cecilie Bay-Richter et al.
BRAIN BEHAVIOR AND IMMUNITY (2015)
Reduction of kynurenic acid to quinolinic acid ratio in both the depressed and remitted phases of major depressive disorder
Jonathan Savitz et al.
BRAIN BEHAVIOR AND IMMUNITY (2015)
Astrocyte and Microglial Control of Glutamatergic Signalling: A Primer on Understanding the Disruptive Role of Chronic Stress
J. Mayhew et al.
JOURNAL OF NEUROENDOCRINOLOGY (2015)
Glutamate and dopamine in schizophrenia: An update for the 21st century
Oliver Howes et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2015)
Systemic immune changes associated with adjuvant interferon-α2b-therapy in stage III melanoma patients: failure at the effector phase?
Ines Chevolet et al.
MELANOMA RESEARCH (2015)
Neuroprotective kynurenine metabolite indices are abnormally reduced and positively associated with hippocampal and amygdalar volume in bipolar disorder
Jonathan Savitz et al.
PSYCHONEUROENDOCRINOLOGY (2015)
Tryptophan-degrading enzymes in tumoral immune resistance
Nicolas van Baren et al.
FRONTIERS IN IMMUNOLOGY (2015)
T cell-NF-κB activation is required for tumor control in vivo
Sarah E. Barnes et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2015)
Antitumour agents as inhibitors of tryptophan 2,3-dioxygenase
Georgios Pantouris et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2014)
Oxidative stress in schizophrenia: a case-control study on the effects on social cognition and neurocognition
Cristina Gonzalez-Liencres et al.
BMC PSYCHIATRY (2014)
Insights from interferon-α-related depression for the pathogenesis of depression associated with inflammation
Carolina Hoyo-Becerra et al.
BRAIN BEHAVIOR AND IMMUNITY (2014)
IDO2 is critical for IDO1-mediated T-cell regulation and exerts a non-redundant function in inflammation
Richard Metz et al.
INTERNATIONAL IMMUNOLOGY (2014)
Inhibition of stress-induced hepatic tryptophan 2,3-dioxygenase exhibits antidepressant activity in an animal model of depressive behaviour
Sinead M. Gibney et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2014)
Plasma L-Tryptophan Concentration in Major Depressive Disorder: New Data and Meta-Analysis
Shintaro Ogawa et al.
JOURNAL OF CLINICAL PSYCHIATRY (2014)
The SOCS3-Independent Expression of IDO2 Supports the Homeostatic Generation of T Regulatory Cells by Human Dendritic Cells
Sara Trabanelli et al.
JOURNAL OF IMMUNOLOGY (2014)
The KMO allele encoding Arg452 is associated with psychotic features in bipolar disorder type 1, and with increased CSF KYNA level and reduced KMO expression
C. Lavebratt et al.
MOLECULAR PSYCHIATRY (2014)
EFFECT OF DOCOSAHEXAENOIC ACID ON HIPPOCAMPAL NEURONS IN HIGH-GLUCOSE CONDITION: INVOLVEMENT OF PI3K/AKT/NUCLEAR FACTOR-κB-MEDIATED INFLAMMATORY PATHWAYS
R. -H. Yang et al.
NEUROSCIENCE (2014)
Impact of inflammation on neurotransmitter changes in major depression: An insight into the action of antidepressants
Brian E. Leonard
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2014)
A review of peripheral biomarkers in major depression: The potential of inflammatory and oxidative stress biomarkers
Adrian L. Lopresti et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2014)
Does tryptophan degradation along the kynurenine pathway mediate the association between pro-inflammatory immune activity and depressive symptoms?
Jacqueline Quak et al.
PSYCHONEUROENDOCRINOLOGY (2014)
Biochemical and Neurotransmitters Changes Associated with Tramadol in Streptozotocin-Induced Diabetes in Rats
Essam Ezzeldin et al.
BIOMED RESEARCH INTERNATIONAL (2014)
Living with the unexplained: coping, distress, and depression among women with chronic fatigue syndrome and/or fibromyalgia compared to an autoimmune disorder
Opal A. McInnis et al.
ANXIETY STRESS AND COPING (2014)
Indoleamine 2,3-dioxygenase 2 (IDO2) and the kynurenine pathway: characteristics and potential roles in health and disease
Amos A. Fatokun et al.
AMINO ACIDS (2013)
Indoleamine 2,3-dioxygenase inhibition attenuates lipopolysaccharide induced persistent microglial activation and depressive-like complications in fractalkine receptor (CX3CR1)-deficient mice
Angela W. Corona et al.
BRAIN BEHAVIOR AND IMMUNITY (2013)
Tryptophan: The key to boosting brain serotonin synthesis in depressive illness
Abdulla A-B Badawy
JOURNAL OF PSYCHOPHARMACOLOGY (2013)
Kynurenines in the CNS: recent advances and new questions
Laszlo Vecsei et al.
NATURE REVIEWS DRUG DISCOVERY (2013)
Connecting Inflammation with Glutamate Agonism in Suicidality
Sophie Erhardt et al.
NEUROPSYCHOPHARMACOLOGY (2013)
3-Hydroxykynurenine: An intriguing molecule exerting dual actions in the Central Nervous System
Ana Laura Colin-Gonzalez et al.
NEUROTOXICOLOGY (2013)
An expanding range of targets for kynurenine metabolites of tryptophan
Trevor W. Stone et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2013)
Identification of selective inhibitors of indoleamine 2,3-dioxygenase 2
Supun M. Bakmiwewa et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2012)
Depression and sickness behavior are Janus-faced responses to shared inflammatory pathways
Michael Maes et al.
BMC MEDICINE (2012)
Kynurenines: from the perspective of major psychiatric disorders
Aye M. Myint
FEBS JOURNAL (2012)
Quinolinic acid, the inescapable neurotoxin
Gilles J. Guillemin
FEBS JOURNAL (2012)
The Role of Indoleamine 2,3-Dioxygenase in a Mouse Model of Neuroinflammation-Induced Depression
Nikoletta Dobos et al.
JOURNAL OF ALZHEIMERS DISEASE (2012)
The role of the kynurenine metabolism in major depression
Aye-Mu Myint et al.
JOURNAL OF NEURAL TRANSMISSION (2012)
Kynurenines in the mammalian brain: when physiology meets pathology
Robert Schwarcz et al.
NATURE REVIEWS NEUROSCIENCE (2012)
Psychoneuroimmunology Meets Neuropsychopharmacology: Translational Implications of the Impact of Inflammation on Behavior
Ebrahim Haroon et al.
NEUROPSYCHOPHARMACOLOGY (2012)
Reversal of tumoral immune resistance by inhibition of tryptophan 2,3-dioxygenase
Luc Pilotte et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Diagnostic classifications in depression and somatization should include biomarkers, such as disorders in the tryptophan catabolite (TRYCAT) pathway
Michael Maes et al.
PSYCHIATRY RESEARCH (2012)
Increased Levels of Kynurenine and Kynurenic Acid in the CSF of Patients With Schizophrenia
Klas R. Linderholm et al.
SCHIZOPHRENIA BULLETIN (2012)
Downregulated Kynurenine 3-Monooxygenase Gene Expression and Enzyme Activity in Schizophrenia and Genetic Association With Schizophrenia Endophenotypes
Ikwunga Wonodi et al.
ARCHIVES OF GENERAL PSYCHIATRY (2011)
Glutamate N-methyl-D-aspartate Receptor Antagonists Rapidly Reverse Behavioral and Synaptic Deficits Caused by Chronic Stress Exposure
Nanxin Li et al.
BIOLOGICAL PSYCHIATRY (2011)
Reversal of imbalance between kynurenic acid and 3-hydroxykynurenine by antipsychotics in medication-naive and medication-free schizophrenic patients
A. M. Myint et al.
BRAIN BEHAVIOR AND IMMUNITY (2011)
Tryptophan 2,3-Dioxygenase (TDO) Inhibitors. 3-(2-(Pyridyl)ethenyl)indoles as Potential Anticancer Immunomodulators
Eduard Dolusic et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
Severe depression is associated with increased microglial quinolinic acid in subregions of the anterior cingulate gyrus: Evidence for an immune-modulated glutamatergic neurotransmission?
Johann Steiner et al.
JOURNAL OF NEUROINFLAMMATION (2011)
An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor
Christiane A. Opitz et al.
NATURE (2011)
Diabetic neuropathy: cellular mechanisms as therapeutic targets
Andrea M. Vincent et al.
NATURE REVIEWS NEUROLOGY (2011)
On the antioxidant properties of kynurenic acid: Free radical scavenging activity and inhibition of oxidative stress
R. Lugo-Huitron et al.
NEUROTOXICOLOGY AND TERATOLOGY (2011)
Effects of PEG-interferon alpha plus ribavirin on tryptophan metabolism in patients with chronic hepatitis C
Stefano Comai et al.
PHARMACOLOGICAL RESEARCH (2011)
The new '5-HT' hypothesis of depression: Cell-mediated immune activation induces indoleamine 2,3-dioxygenase, which leads to lower plasma tryptophan and an increased synthesis of detrimental tryptophan catabolites (TRYCATs), both of which contribute to the onset of depression
M. Maes et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2011)
Inflammation-associated depression: From serotonin to kynurenine
Robert Dantzer et al.
PSYCHONEUROENDOCRINOLOGY (2011)
Impaired Kynurenine Pathway Metabolism in The Prefrontal Cortex of Individuals With Schizophrenia
Korrapati V. Sathyasaikumar et al.
SCHIZOPHRENIA BULLETIN (2011)
Novel 1-alkyl-tryptophan derivatives downregulate IDO1 and IDO2 mRNA expression induced by interferon-gamma in dendritic cells
Ting Sun et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2010)
Hydroxyamidine Inhibitors of Indoleamine-2,3-dioxygenase Potently Suppress Systemic Tryptophan Catabolism and the Growth of IDO-Expressing Tumors
Holly K. Koblish et al.
MOLECULAR CANCER THERAPEUTICS (2010)
CSF concentrations of brain tryptophan and kynurenines during immune stimulation with IFN-α: relationship to CNS immune responses and depression
C. L. Raison et al.
MOLECULAR PSYCHIATRY (2010)
Effects of tryptophan loading on human cognition, mood, and sleep
B. Y. Silber et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2010)
IDO1 and IDO2 are expressed in human tumors: levo- but not dextro-1-methyl tryptophan inhibits tryptophan catabolism
Stefan Loeb et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2009)
Lipopolysaccharide-induced depressive-like behavior is mediated by indoleamine 2,3-dioxygenase activation in mice
J. C. O'Connor et al.
MOLECULAR PSYCHIATRY (2009)
Mechanism for Quinolinic Acid Cytotoxicity in Human Astrocytes and Neurons
Nady Braidy et al.
NEUROTOXICITY RESEARCH (2009)
Inhibitors of indoleamine-2,3-dioxygenase for cancer therapy: can we see the wood for the trees?
Stefan Loeb et al.
NATURE REVIEWS CANCER (2009)
COX-2 inhibition in schizophrenia and major depression
Norbert Mueller et al.
CURRENT PHARMACEUTICAL DESIGN (2008)
Examining a bidirectional association between depressive symptoms and diabetes
Sherita Hill Golden et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2008)
From inflammation to sickness and depression: when the immune system subjugates the brain
Robert Dantzer et al.
NATURE REVIEWS NEUROSCIENCE (2008)
IDO and regulatory T cells:: a role for reverse signalling and non-canonical NF-κB activation
Paolo Puccetti et al.
NATURE REVIEWS IMMUNOLOGY (2007)
Combined dexamethasone/corticotropin releasing hormone test predicts treatment response in major depression -: A potential biomarker?
Marcus Ising et al.
BIOLOGICAL PSYCHIATRY (2007)
Kynurenine pathway in major depression:: Evidence of impaired neuroprotection
Aye-Mu Myint et al.
JOURNAL OF AFFECTIVE DISORDERS (2007)
Twenty years of research on cytokine-induced sickness behavior
Robert Dantzer et al.
BRAIN BEHAVIOR AND IMMUNITY (2007)
Inhibition of indoleamine 2,3-dioxygenase in dendritic cells by stereoisomers of 1-methyl-tryptophan correlates with antitumor responses
De-Yan Hou et al.
CANCER RESEARCH (2007)
Plasma cytokine profiles in depressed patients who fail to respond to selective serotonin reuptake inhibitor therapy
Sinead M. O'Brien et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2007)
Upregulation of the initiating step of the kynurenine pathway in postmortem anterior cingulate cortex from individuals with schizophrenia and bipolar disorder
CL Miller et al.
BRAIN RESEARCH (2006)
Biochemical and medical aspects of the indoleamine 2,3-dioxygenase-initiated L-tryptophan metabolism
O Takikawa
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
An acute hyperglycemia or acidosis-induced changes of indolamines level correlates with PKC-α expression in rat brain
R Ramakrishnan et al.
BRAIN RESEARCH BULLETIN (2005)
Branched-chain amino acids and brain function
JD Fernstrom
JOURNAL OF NUTRITION (2005)
Aspirin down-regulates tryptophan degradation in stimulated human peripheral blood mononuclear cells in vitro
K Schroecksnadel et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2005)
Quinolinic acid selectively induces apoptosis of human astrocytes: potential role in AIDS dementia complex
Gilles J. Guillemin et al.
JOURNAL OF NEUROINFLAMMATION (2005)
Expression of indoleamine 2,3-dioxygenase and production of quinolinic acid by human microglia, astrocytes, and neurons
GJ Guillemin et al.
GLIA (2005)
Expression of the kynurenine pathway enzyme tryptophan 2,3-dioxygenase is increased in the frontal cortex of individuals with schizophrenia
CL Miller et al.
NEUROBIOLOGY OF DISEASE (2004)
Do antidepressants regulate how cortisol affects the brain?
CM Pariante et al.
PSYCHONEUROENDOCRINOLOGY (2004)
Inhibitory action of clozapine on rat ventral tegmental area dopamine neurons following increased levels of endogenous kynurenic acid
L Schwieler et al.
NEUROPSYCHOPHARMACOLOGY (2003)
Tryptophan and the immune response
JR Moffett et al.
IMMUNOLOGY AND CELL BIOLOGY (2003)
Quinolinic acid upregulates chemokine production and chemokine receptor expression in astrocytes
GJ Guillemin et al.
GLIA (2003)
Tryptophan deprivation sensitizes activated T cells to apoptosis prior to cell division
GK Lee et al.
IMMUNOLOGY (2002)
Endogenous kynurenines as targets for drug discovery and development
TW Stone et al.
NATURE REVIEWS DRUG DISCOVERY (2002)
Quinolinic acid stimulates synaptosomal glutamate release and inhibits glutamate uptake into astrocytes
RG Tavares et al.
NEUROCHEMISTRY INTERNATIONAL (2002)
Increased depressive ratings in patients with hepatitis C receiving interferon-α-based immunotherapy are related to interferon-α-induced changes in the serotonergic system
S Bonaccorso et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2002)
Association between decreased serum tryptophan concentrations and depressive symptoms in cancer patients undergoing cytokine therapy
L Capuron et al.
MOLECULAR PSYCHIATRY (2002)
Kynurenic acid levels are elevated in the cerebrospinal fluid of patients with schizophrenia
S Erhardt et al.
NEUROSCIENCE LETTERS (2001)
Kynurenine pathway metabolism in human astrocytes: a paradox for neuronal protection
GJ Guillemin et al.
JOURNAL OF NEUROCHEMISTRY (2001)
The prevalence of comorbid depression in adults with diabetes - A meta-analysis
RJ Anderson et al.
DIABETES CARE (2001)
Similarities and differences in the neuronal death processes activated by 3OH-kynurenine and quinolinic acid
A Chiarugi et al.
JOURNAL OF NEUROCHEMISTRY (2001)
Heme: A regulator of rat hepatic tryptophan 2,3-dioxygenase?
SY Ren et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2000)
Quinolinic acid inhibits glutamate uptake into synaptic vesicles from rat brain
RG Tavares et al.
NEUROREPORT (2000)
IDO induction in IFN-gamma activated astroglia: A role in improving cell viability during oxidative stress
RS Grant et al.
REDOX REPORT (2000)
Characterisation of kynurenine pathway metabolism in human astrocytes and implications in neuropathogenesis
GJ Guillemin et al.
REDOX REPORT (2000)
Share Paper
